Uta Oelschlaegel
- Hematology top 1%
- Acute Myeloid Leukemia Research 24
- Hematopoietic Stem Cell Transplantation 17
- Multiple Myeloma Research and Treatments 5
- Chronic Myeloid Leukemia Treatments 5
- Genetics top 5%
- Blood disorders and treatments 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Oncology top 10%
-
- Immunotherapy and Immune Responses 5
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Gerhard EhningerMartin BornhäuserChristian ThiedeUwe PlatzbeckerBrigitte MohrJens PassauerFrank PistroschKay Herbrig
- Cited by
- HematologyGeneticsOncology
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Uta Oelschlaegel
38 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Hematology 770
- Genetics 203
- Oncology 302
- Immunology 191
- Public Health, Environmental and Occupational Health 219
Countries citing papers authored by Uta Oelschlaegel
This map shows the geographic impact of Uta Oelschlaegel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uta Oelschlaegel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uta Oelschlaegel more than expected).
Fields of papers citing papers by Uta Oelschlaegel
This network shows the impact of papers produced by Uta Oelschlaegel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uta Oelschlaegel. The network helps show where Uta Oelschlaegel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Uta Oelschlaegel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 16 | |
| 3 | 2021 | 3 | |
| 4 | 2020 | 11 | |
| 5 | 2016 | 10 | |
| 6 | 2011 | 293 | |
| 7 | 2011 | 67 | |
| 8 | 2010 | 118 | |
| 9 | 2009 | 26 | |
| 10 | 2008 | 5 | |
| 11 | 2008 | 23 | |
| 12 | 2007 | 22 | |
| 13 | 2006 | 33 | |
| 14 | 2006 | 26 | |
| 15 | 2005 | 125 | |
| 16 | 2005 | 1 | |
| 17 | 2003 | 19 | |
| 18 | 2001 | 29 | |
| 19 | 2001 | 4 | |
| 20 | 1997 | 16 |
About Uta Oelschlaegel
Uta Oelschlaegel is a scholar working on Hematology, Genetics and Immunology, having authored 41 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Hematopoietic Stem Cell Transplantation (17 papers), Multiple Myeloma Research and Treatments (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Immunotherapy and Immune Responses (5 papers), Blood disorders and treatments (4 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (770 citations), Genetics (203 citations) and Oncology (302 citations). Uta Oelschlaegel has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Gerhard Ehninger, Martin Bornhäuser, Christian Thiede, Uwe Platzbecker, Brigitte Mohr, Jens Passauer, Frank Pistrosch, Kay Herbrig, Christoph Röllig and Johannes Schetelig. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.